Breaking News, Financial News

4Q Financial Reports: West Pharmaceutical Services, Inc.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

West Pharmaceutical Services, Inc.

4Q Revenue: $195.6 million (+38%)

4Q Earnings: $12.9 million (+77%)

FY Revenues: $699.7 million (+29%)

FY Earnings: $45.2 million (+35%)

Comments: Pharmaceutical systems business sales grew 9.5% to $136.4 million in the quarter and gross profit in the segment was $44 million, or 32% of sales. Monarch Laboratories, acquired in February 2005, and Medimop Medical Projects, acquired in August 2005, are included in the Pharmaceutical Systems segment. Improvement in the segment’s gross margin was a result of production efficiencies, higher margin products and services in the Monarch Labs and Medimop Medical Projects businesses, and lower workers compensation costs.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters